Sponsor or institution

Clinical trials and research at Celgene

• 9Clinical trials
• 42Countries

Newest trials

All recruiting trials (9)

• Irafamdastat (BMS-986368) relative bioavailability and food effect in healthy adults

  This study tests how the body absorbs irafamdastat when taken under different conditions and whether food changes its absorption in healthy adults.

  Recruiting Phase 1 Celgene · Anaheim, California · NCT07837115

• Mezigdomide plus elranatamab for relapsed or refractory multiple myeloma

  This test tries adding mezigdomide to elranatamab (with dexamethasone) to see if it is safe and can help adults with relapsed or refractory multiple myeloma who have had 1–4 prior treatments (eligibility differs by phase).

  Recruiting at 20 sites Phase 1/2 Celgene · Birmingham, Alabama and 21 other locations · NCT06988488

• Golcadomide plus rituximab versus investigator's choice for relapsed or refractory follicular lymphoma

  This trial tests whether combining golcadomide with rituximab works better than standard investigator‑selected treatments for adults with relapsed or refractory follicular lymphoma who have had at least one prior systemic therapy.

  Recruiting at 62 sites Phase 3 Celgene · Birmingham, Alabama and 159 other locations · NCT06911502

• BMS-986368 for treating agitation in Alzheimer's disease

  This will test whether BMS-986368 can reduce agitation in people with biomarker-confirmed Alzheimer's disease.

  Recruiting at 32 sites Phase 2 Celgene · Homewood, Alabama and 76 other locations · NCT06808984

• BMS-986368 to reduce spasticity in people with MS

  This will test whether BMS-986368 reduces spasticity in adults with multiple sclerosis.

  Recruiting at 48 sites Phase 2 Celgene · Birmingham, Alabama and 60 other locations · NCT06782490

• Comparing two treatment combinations for relapsed or refractory multiple myeloma

  This study is testing whether a new combination of mezigdomide, bortezomib, and dexamethasone works better than another combination for people with relapsed or refractory multiple myeloma who have already tried some treatments.

  Recruiting at 42 sites Phase 3 Celgene · Los Alamitos, California and 265 other locations · NCT05519085

• Evaluating the safety and pharmacokinetics of Luspatercept in children with beta-thalassemia

  This study is testing a new drug called Luspatercept to see if it's safe and how it works in children with beta-thalassemia, starting with teens and then including younger kids.

  Recruiting at 22 sites Phase 2 Celgene · Los Angeles, California and 25 other locations · NCT04143724

• Evaluating long-term safety of luspatercept for patients previously in other trials

  This study is testing the long-term safety of luspatercept for people with myelodysplastic syndromes, beta-thalassemia, and certain blood cancers who have already participated in other luspatercept trials.

  Recruiting at 27 sites Phase 3 Celgene · Los Angeles, California and 142 other locations · NCT04064060

• Long-term follow-up for patients treated with gene-modified T cells

  This study is checking how well gene-modified T-cell therapy works and what side effects it might have for both kids and adults who have already received this treatment in the past.

  Recruiting at 175 sites Phase 2/3 Celgene · Birmingham, Alabama and 224 other locations · NCT03435796

Quick answers

How many clinical trials run by Celgene are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 42 countries. The most sites are in United States (9 trials), Germany (7 trials), China (6 trials), Greece (6 trials), Australia (6 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 3: 3, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →